Published in

Ferrata Storti Foundation, Haematologica, p. haematol.2018.194399

DOI: 10.3324/haematol.2018.194399

Links

Tools

Export citation

Search in Google Scholar

Lenalidomide plus bendamustine-rituximab does not overcome the adverse impact of TP53 mutations in mantle cell lymphoma

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Red circle
Preprint: archiving forbidden
Red circle
Postprint: archiving forbidden
Green circle
Published version: archiving allowed
Data provided by SHERPA/RoMEO